MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
Background: Metabolic side effects associated with atypical antipsychotics represent a major challenge in the clinical management of schizophrenia, contributing to poor treatment adherence and an increased risk of relapse. MicroRNAs (miRNAs) have emerged as promising diagnostic biomarkers for schizo...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2026-03-01
|
| Col·lecció: | Therapeutic Advances in Psychopharmacology |
| Accés en línia: | https://doi.org/10.1177/20451253261430603 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|